Search
Now showing items 1-6 of 6
Effect of Levosimendan in Patients with Severe Systolic Heart Failure and Worsening Renal Function
(ARQUIVOS BRASILEIROS CARDIOLOGIA, 2012)
Background: Levosimendan, a calcium sensitizer, increases the sensitivity of the heart to calcium, thus increasing myocardial contractility without a rise in intracellular calcium. It was recently shown that levosimendan ...
Letter to editor: Clinical profile and predictors of in-hospital outcome in patients with heart failure
(ELSEVIER IRELAND LTD, 2011)
…
CA125 in heart failure: Implications for immunoinflammatory activity
(ELSEVIER IRELAND LTD, 2011)
…
The relationship between D-dimer level and the development of atrial fibrillation in patients with systolic heart failure
(SPRINGER, 2012)
Heart failure (HF) is one of the most common and leading cause of death worldwide. Clinical trials provide evidence that the development of atrial fibrillation (AF) is a marker of poor prognosis in patients with HF. ...
Increased d-dimer levels predict cardiovascular mortality in patients with systolic heart failure
(SPRINGER, 2012)
D-dimer is a fibrin degradation product, and is implicated in pathologies of cardiovascular system. Thrombosis within the vascular system in relation with inflammation and stasis might be associated with poor prognosis in ...
Lymphocytopenia is associated with poor NYHA functional class in chronic heart failure patients with reduced ejection fraction
(TURKISH SOC CARDIOLOGY, 2015)
Objective: In heart failure (HF) patients, functional capacity has been demonstrated to be a marker of poor prognosis, independent of left ventricular ejection fraction (EF). Lymphocyte count is currently recognized in ...